Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Integrating the Neurodevelopmental and Dopamine Hypotheses of Schizophrenia and the Role of Cortical Excitation-Inhibition Balance
Oliver Howes, Ekaterina Shatalina
Biological Psychiatry (2022) Vol. 92, Iss. 6, pp. 501-513
Open Access | Times Cited: 151

Showing 1-25 of 151 citing articles:

The synaptic hypothesis of schizophrenia version III: a master mechanism
Oliver Howes, Ellis Chika Onwordi
Molecular Psychiatry (2023) Vol. 28, Iss. 5, pp. 1843-1856
Open Access | Times Cited: 83
Neuroimaging in schizophrenia: an overview of findings and their implications for synaptic changes
Oliver Howes, Connor Cummings, George E. Chapman, et al.
Neuropsychopharmacology (2022) Vol. 48, Iss. 1, pp. 151-167
Open Access | Times Cited: 77
The schizophrenia syndrome, circa 2024: What we know and how that informs its nature
Rajiv Tandon, Henry A. Nasrallah, Schahram Akbarian, et al.
Schizophrenia Research (2023) Vol. 264, pp. 1-28
Open Access | Times Cited: 57
Virtual brain twins: from basic neuroscience to clinical use
Huifang Wang, Paul Triebkorn, Martin Breyton, et al.
National Science Review (2024) Vol. 11, Iss. 5
Open Access | Times Cited: 22
Co Single-Atom Nanozymes for the Simultaneous Electrochemical Detection of Uric Acid and Dopamine in Biofluids
Yiyi Liu, Yong Zhang, Cuncun Wang, et al.
ACS Applied Nano Materials (2024) Vol. 7, Iss. 6, pp. 6273-6283
Closed Access | Times Cited: 18
Trace amine-associated receptor 1 (TAAR1) agonism as a new treatment strategy for schizophrenia and related disorders
Els F. Halff, Grazia Rutigliano, Anna Garcia-Hidalgo, et al.
Trends in Neurosciences (2022) Vol. 46, Iss. 1, pp. 60-74
Open Access | Times Cited: 58
Neurodevelopmental disturbances in schizophrenia: evidence from genetic and environmental factors
Andrea Schmitt, Peter Falkai, Sergi Papiol
Journal of Neural Transmission (2022) Vol. 130, Iss. 3, pp. 195-205
Open Access | Times Cited: 43
Roles of the Oxytocin Receptor (OXTR) in Human Diseases
Karolina Pierzynowska, Lidia Gaffke, Magdalena Żabińska, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 4, pp. 3887-3887
Open Access | Times Cited: 29
Modulators of GABAA receptor-mediated inhibition in the treatment of neuropsychiatric disorders: past, present, and future
Scott M. Thompson
Neuropsychopharmacology (2023) Vol. 49, Iss. 1, pp. 83-95
Closed Access | Times Cited: 29
GRIN2A (NR2A): a gene contributing to glutamatergic involvement in schizophrenia
Paul J. Harrison, David M. Bannerman
Molecular Psychiatry (2023) Vol. 28, Iss. 9, pp. 3568-3572
Open Access | Times Cited: 22
New Drug Treatments for Schizophrenia: A Review of Approaches to Target Circuit Dysfunction
Oliver Howes, Eleanor Dawkins, Maria Lobo, et al.
Biological Psychiatry (2024) Vol. 96, Iss. 8, pp. 638-650
Open Access | Times Cited: 14
Parvalbumin interneuron deficits in schizophrenia
Oscar Marı́n
European Neuropsychopharmacology (2024) Vol. 82, pp. 44-52
Open Access | Times Cited: 10
Baseline symptom-related white matter tracts predict individualized treatment response to 12-week antipsychotic monotherapies in first-episode schizophrenia
Ying Chen, Shanming Liu, Bo Zhang, et al.
Translational Psychiatry (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 9
Doublecortin-Expressing Neurons in Human Cerebral Cortex Layer II and Amygdala from Infancy to 100 Years Old
Yanan Li, Dandan Hu, Xiao-Lu Cai, et al.
Molecular Neurobiology (2023) Vol. 60, Iss. 6, pp. 3464-3485
Open Access | Times Cited: 19
Resolving the Delusion Paradox
Predrag Petrović, Philipp Sterzer
Schizophrenia Bulletin (2023) Vol. 49, Iss. 6, pp. 1425-1436
Open Access | Times Cited: 17
Novel Compounds in the Treatment of Schizophrenia—A Selective Review
Eva-Maria Tsapakis, Kalliopi Diakaki, Apostolos Miliaras, et al.
Brain Sciences (2023) Vol. 13, Iss. 8, pp. 1193-1193
Open Access | Times Cited: 17
Electrochemical sensors for simultaneous detection of dopamine and uric acid based on a composite of electrochemically reduced graphene oxide and PEDOT:PSS-modified glassy carbon electrode
Shafa Aini Hasnawati Ta'alia, Eti Rohaeti, Budi Riza Putra, et al.
Results in Chemistry (2023) Vol. 6, pp. 101024-101024
Open Access | Times Cited: 16
Trace amine-associated receptor 1 (TAAR1) agonism for psychosis: a living systematic review and meta-analysis of human and non-human data
Spyridon Siafis, Virginia Chiocchia, Malcolm Macleod, et al.
Wellcome Open Research (2024) Vol. 9, pp. 182-182
Open Access | Times Cited: 7
Identification and treatment of individuals with childhood-onset and early-onset schizophrenia
Christoph U. Correll, Celso Arango, Birgitte Fagerlund, et al.
European Neuropsychopharmacology (2024) Vol. 82, pp. 57-71
Open Access | Times Cited: 6
Exploring causal mechanisms of psychosis risk
Dominic Oliver, Edward Chesney, Alexis E. Cullen, et al.
Neuroscience & Biobehavioral Reviews (2024) Vol. 162, pp. 105699-105699
Open Access | Times Cited: 6
Excitation/inhibition imbalance in schizophrenia: a meta-analysis of inhibitory and excitatory TMS-EMG paradigms
Orsolya Lányi, Boróka Koleszár, Alexander Schulze Wenning, et al.
Schizophrenia (2024) Vol. 10, Iss. 1
Open Access | Times Cited: 6
Dual-attribute ring-star neural network
Zhicheng Liao, Jiajun Ouyang, Minglin Ma
Nonlinear Dynamics (2024)
Closed Access | Times Cited: 6
Advances in the understanding of the pathophysiology of schizophrenia and bipolar disorder through induced pluripotent stem cell models
Andrea Perrottelli, Francesco Flavio Marzocchi, Edoardo Caporusso, et al.
Journal of Psychiatry and Neuroscience (2024) Vol. 49, Iss. 2, pp. E109-E125
Open Access | Times Cited: 5
Nanosystems for Brain Targeting of Antipsychotic Drugs: An Update on the Most Promising Nanocarriers for Increased Bioavailability and Therapeutic Efficacy
Maria Daniela Ferreira, Joana Duarte, Francisco Veiga, et al.
Pharmaceutics (2023) Vol. 15, Iss. 2, pp. 678-678
Open Access | Times Cited: 14
A new era for schizophrenia drug development – Lessons for the future
Kiri Granger, Michael Sand, Sheryl Caswell, et al.
Drug Discovery Today (2023) Vol. 28, Iss. 7, pp. 103603-103603
Open Access | Times Cited: 14
Page 1 - Next Page

Scroll to top